Literature DB >> 27942046

Measuring and reporting disease progression in subclinical rheumatic heart disease.

Ganesan Karthikeyan1.   

Abstract

Entities:  

Keywords:  RENAL DISEASE; VALVULAR DISEASE

Year:  2016        PMID： 27942046      PMCID： PMC5133391          DOI： 10.1136/heartasia-2016-010857

Source DB:  PubMed          Journal:  Heart Asia        ISSN： 1759-1104


× No keyword cloud information.
  9 in total

1.  Prevalence of rheumatic heart disease in children and young adults in Nicaragua.

Authors:  John A Paar; Nubia M Berrios; John D Rose; Mercedes Cáceres; Rodolfo Peña; Wilton Pérez; Mario Chen-Mok; Erik Jolles; James B Dale
Journal:  Am J Cardiol       Date:  2010-04-27       Impact factor: 2.778

2.  Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study.

Authors:  Anita Saxena; Sivasubramanian Ramakrishnan; Ambuj Roy; Sandeep Seth; Anand Krishnan; Puneet Misra; Mani Kalaivani; Balram Bhargava; Marcus D Flather; Philip P A Poole-Wilson
Journal:  Heart       Date:  2011-11-10       Impact factor: 5.994

Review 3.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

4.  Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).

Authors:  Liesl Zühlke; Ganesan Karthikeyan; Mark E Engel; Sumathy Rangarajan; Pam Mackie; Blanche Cupido-Katya Mauff; Shofiqul Islam; Rezeen Daniels; Veronica Francis; Stephen Ogendo; Bernard Gitura; Charles Mondo; Emmy Okello; Peter Lwabi; Mohammed M Al-Kebsi; Christopher Hugo-Hamman; Sahar S Sheta; Abraham Haileamlak; Wandimu Daniel; Dejuma Yadeta Goshu; Senbeta G Abdissa; Araya G Desta; Bekele A Shasho; Dufera M Begna; Ahmed ElSayed; Ahmed S Ibrahim; John Musuku; Fidelia Bode-Thomas; Christopher C Yilgwan; Ganiyu A Amusa; Olukemi Ige; Basil Okeahialam; Christopher Sutton; Rajeev Misra; Azza Abul Fadl; Neil Kennedy; Albertino Damasceno; Mahmoud U Sani; Okechukwu S Ogah; Taiwo OlunugaHuda H M Elhassan; Ana Olga Mocumbi; Abiodun M Adeoye; Phindile Mntla; Dike Ojji; Joseph Mucumbitsi; Koon Teo; Salim Yusuf; Bongani M Mayosi
Journal:  Circulation       Date:  2016-10-04       Impact factor: 29.690

5.  Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations.

Authors:  Maneesha Bhaya; Rajesh Beniwal; Sadiak Panwar; Raja Babu Panwar
Journal:  Echocardiography       Date:  2011-08-19       Impact factor: 1.724

6.  Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease?

Authors:  Marc Rémond; David Atkinson; Andrew White; Alex Brown; Jonathan Carapetis; Bo Remenyi; Kathryn Roberts; Graeme Maguire
Journal:  Int J Cardiol       Date:  2015-07-06       Impact factor: 4.164

7.  Echocardiography screening to detect rheumatic heart disease: A cohort study of schoolchildren in French Pacific Islands.

Authors:  Mariana Mirabel; Thomas Fauchier; Raoul Bacquelin; Muriel Tafflet; Agnès Germain; Corinne Robillard; Bernard Rouchon; Eloi Marijon; Xavier Jouven
Journal:  Int J Cardiol       Date:  2015-04-02       Impact factor: 4.164

8.  Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection.

Authors:  Andrea Beaton; Emmy Okello; Twalib Aliku; Sulaiman Lubega; Peter Lwabi; Charles Mondo; Robert McCarter; Craig Sable
Journal:  Pediatr Cardiol       Date:  2014-05-15       Impact factor: 1.655

9.  The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study.

Authors:  Liesl Zühlke; Mark E Engel; Carolina E Lemmer; Marnie van de Wall; Simpiwe Nkepu; Alet Meiring; Michael Bestawros; Bongani M Mayosi
Journal:  BMC Cardiovasc Disord       Date:  2016-02-19       Impact factor: 2.298
  9 in total
  2 in total

1.  Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.

Authors:  Andrea Beaton; Twalib Aliku; Alyssa Dewyer; Marni Jacobs; Jiji Jiang; Chris T Longenecker; Sulaiman Lubega; Robert McCarter; Mariana Mirabel; Grace Mirembe; Judith Namuyonga; Emmy Okello; Amy Scheel; Emmanuel Tenywa; Craig Sable; Peter Lwabi
Journal:  Circulation       Date:  2017-09-27       Impact factor: 29.690

2.  An investment case for the prevention and management of rheumatic heart disease in the African Union 2021-30: a modelling study.

Authors:  Matthew M Coates; Karen Sliwa; David A Watkins; Liesl Zühlke; Pablo Perel; Florence Berteletti; Jean-Luc Eiselé; Sheila L Klassen; Gene F Kwan; Ana O Mocumbi; Dorairaj Prabhakaran; Mahlet Kifle Habtemariam; Gene Bukhman
Journal:  Lancet Glob Health       Date:  2021-05-10       Impact factor: 38.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.